Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 3 / Review Article
Clinical Efficacy and Safety of Buyang Huanwu Decoction for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials Table 3 Summary of GRADE on evidences of outcomes of Bu-yang Huan-wu decoction for acute ischemic stroke.
Quality assessment Number of patients Effect Quality Importance Number of studies Design Risk of bias Inconsistency Indirectness Imprecision Other considerations Trial Control Relative (95% CI) Absolute Effective rate 17 Randomized trials Very serious No serious inconsistency No serious indirectness No serious imprecision Reporting bias 696/747 (93.2%) 535/697 (76.8%) RR 1.18 (1.12 to 1.24) 138 more per 1000 (from 92 more to 184 more) ⨁ ○○○ very lowImportant 75% 135 more per 1000 (from 90 more to 180 more) Neurological deficit scores (Modified Edinburgh–Scandinavian Stroke Scale) 9 Randomized trials Very serious No serious inconsistency No serious indirectness No serious imprecision Reporting bias 409 377 — MD 4.65 lower (6.57 to 2.72 lower) ⨁ ○○○ very lowImportant Neurological deficit scores (ESS) 1 Randomized trials Very serious No serious inconsistency No serious indirectness No serious imprecision None 33 33 — MD 7.99 higher (3.96 to 12.02 higher) ⨁ ⨁ ○○ lowImportant